BEAM (Beam Therapeutics Inc.) Stock Market Reviews

crown

search

Read and share opinions on BEAM (Beam Therapeutics Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market.

BEAM

Beam Therapeutics Inc.

clarify Biotechnology

bookmark Healthcare

public United States

Sell Neutral Buy

Latest News

Beam Therapeutics (BEAM): Exploring Valuation as Clinical Milestones Revitalize Investor Interest
Nov 14, 2025
Beam Therapeutics to Participate in 2025 Jefferies London Healthcare Conference
Nov 12, 2025
Clear Street Raises PT on Beam Therapeutics (BEAM) to $37 Following Q3 Results
Nov 11, 2025
Beam Therapeutics (BEAM): Losses Worsen as Profitability Remains Elusive Despite Rapid Revenue Growth Forecasts
Nov 5, 2025
Beam Therapeutics Inc. (BEAM) Reports Q3 Loss, Lags Revenue Estimates
Nov 4, 2025
Beam Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Updates
Nov 4, 2025
Beam Therapeutics to Present Updated Data from BEACON Phase 1/2 Trial of BEAM-101 in Sickle Cell Disease at American Society of Hematology (ASH) Annual Meeting
Nov 3, 2025
Beam Therapeutics (BEAM) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
Oct 29, 2025
Beam Therapeutics Inc. (BEAM) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
Oct 28, 2025

Reviews